Skip to main content
TipRanks
Go Ultimate75% OFF

Oruka Therapeutics (0H79) Ownership - Who Owns Oruka Therapeutics?

0 Followers

Oruka Therapeutics (0H79) Ownership Overview

  • 7.49% Insiders
  • 29.00% Mutual Funds
  • 20.58% Other Institutional Investors
  • 14.95% ETFs
  • 27.98% Public Companies and Individual Investors

The ownership structure of Oruka Therapeutics (GB:0H79) stock is a mix of institutional, retail, and individual investors. Approximately 64.54% of the company’s stock is owned by Institutional Investors, 7.49% is owned by Insiders, and 27.98% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Sep 14, 2026Laura Lee Sandler$86,713
Sep 14, 2026Paul T. Quinlan$99,443
Sep 14, 2026Lawrence Otto Klein$234,681
Jun 30, 2026Fairmount Funds Management Llc$300,014,406

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Woodline Partners Lp$17,414,701
Dec 31, 2025Blackstone Inc.$35,323,516
Dec 31, 2025Perceptive Advisors Llc$44,752,745

Top Shareholders

GB:0H79 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.5,210,214Institution7.68%―
Vanguard3,762,363Institution5.55%―
Fairmount Funds Management Llc3,705,262Insider5.46%―
Peter Harwin3,705,262Institution5.46%―
Ishares2,548,610Institution3.76%―
Vanguard Index Funds2,305,645Institution3.40%―
Fidelity Mt. Vernon Street Trust2,015,491Institution2.97%―
Spdr1,869,063Institution2.76%―
Peter Kolchinsky1,554,597Institution2.29%―
Smallcap World Fund Inc1,527,592Institution2.25%―

Top Mutual Fund Holders

GB:0H79 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds2,305,645Institution3.40%―
Fidelity Mt. Vernon Street Trust2,015,491Institution2.97%―
Smallcap World Fund Inc1,527,592Institution2.25%―
Fidelity Securities Fund1,462,630Institution2.16%―
Fidelity Select Portfolios1,442,683Institution2.13%―
New Economy Fund1,323,308Institution1.95%―
Fidelity Advisor Series Vii1,165,386Institution1.72%―
Fidelity Salem Street Trust725,381Institution1.07%―
Fidelity Concord Street Trust513,840Institution0.76%―
Franklin Strategic Series504,275Institution0.74%―

FAQ

Who Owns Oruka Therapeutics (GB:0H79)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 64.54% of the company's stock is held by institutional investors, 7.49% is held by insiders, and 27.98% is held by public companies and individual investors.
What percentage of Oruka Therapeutics (GB:0H79) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 64.54% of Oruka Therapeutics (GB:0H79) stock is held by institutional investors: 29.00% by mutual funds, 14.95% by ETFs and 20.58% by other institutional investors.
What percentage of Oruka Therapeutics (GB:0H79) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 27.98% of Oruka Therapeutics (GB:0H79) stock is held by public companies and individual investors.
Who owns the most shares of Oruka Therapeutics (GB:0H79)?
BlackRock, Inc. owns the most shares of Oruka Therapeutics (GB:0H79).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.